Giovanni Caforio
Giovanni Caforio is the former CEO of Bristol-Myers Squibb and has recently taken on the role of CEO at Novartis. With extensive experience in the pharmaceutical industry and a strong understanding of both the American and European markets, Caforio is poised to lead Novartis into its next phase of growth. His appointment comes at a crucial time as the company navigates challenges in the healthcare landscape and aims to strengthen its market position.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Switzerland | 1 | 6.00 | 0.06% | +0% | 8,654,622 | 5,509 | $700,000 | 446$ |
| Totals | 1 | 8,654,622 | 5,509 | $700,000 | 446$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Giovanni Caforio has been elected as the chairman of Novartis, and expectations are high for his leadership.
6
Switzerland:
Giovanni Caforio was elected as the new chairman of the board with over 98 percent of the votes.
8
Switzerland:
Giovanni Caforio is the designated successor to Jörg Reinhardt at Novartis.
6